PubMed COVID-19 Clinical Care
2221 - 2230 of 2382 results found
Role of vitamin D3 in selected pulmonary diseases with particular emphasis on lung fibrosis
Description
INTRODUCTION AND OBJECTIVE: For many years vitamin D3 was known only as a regulator of the calcium-phosphate and water-electrolyte balances. Recent studies have paid special attention to other biological effects of calcitriol (the bioactive form of
Rapid-cycle designs to adapt interventions for COVID-19 in safety-net healthcare systems
Description
Racial/ethnic minority, low socioeconomic status, and rural populations are disproportionately affected by COVID-19. Developing and evaluating interventions to address COVID-19 testing and vaccination among these populations are crucial to improving
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-Control Investigation
Description
CONCLUSIONS: From caregiver interviews, we clarify household and community exposures associated with MIS-C; however, we did not confirm prior associations between sociodemographic factors and MIS-C.
Regional peak flow as a novel approach to assess regional pulmonary mechanics by electrical impedance tomography: an observational validation study
Description
CONCLUSIONS: A RPF approach for quantifying regional lung mechanics showed a moderate to good agreement in coronavirus disease 2019 (COVID-19) related ARDS patients on CMV compared to the compliance-based approach. This, in addition to being
Real-time detection of SARS-CoV-2 in clinical samples via ultrafast ligation-dependent RNA transcription amplification
Description
RNA has been recognized as an important biomarker of many infectious pathogens; thus, sensitive, simple and rapid detection of RNA is urgently required for the control of epidemics. Herein, we report an ultrafast ligation-dependent RNA transcription
Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report
Description
CONCLUSIONS: Excellent short-term outcomes have been reported in patients with COVID-19 vaccine associated myocarditis. Our case shows that long-term outcomes may not be benign in everyone, particularly in those who develop myocardial scar.
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies
Description
CONCLUSIONS: SARS-CoV-2 vaccination in CIDP and MMN patients does not seem to be associated with an increased risk of relapse at primary endpoint, although a slightly increased risk in CIDP patients was found compared to the 3 months before
Recurrent Reactive Infectious Mucocutaneous Eruption (RIME): A Retrospective Cohort Study
Description
No abstract
